glp 1 and crohn's disease glp-1 COMMIT-CD: A Phase 3b trial evaluating the efficacy & safety of concomitant use of a dual GLP-1/GIP receptor agonist & IL-23p19 Inflammatory bowel disease: GLP-1 receptor

Bioactive peptides, which possess distinct biological activities, are particularly intriguing

No necesitas ser un experto para entenderlo

If pregnant or breastfeeding, be sure to discuss the benefits and risks with your doctor

Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were measured using an automatic biochemical analyzer to assess liver injury

The market is driven by the expanding clinical indication of these therapies, which are now evolving from handling Type 2 diabetes to long-term chronic weight management and even cardiovascular risk reduction

Clinicians often recommend rotating injection sites, reviewing hypoglycemia precautions when used with insulin or sulfonylureas, and emphasizing missed-dose rules